Mycenax Biotech (4726) — Capital Reinvestment Ratio
Mycenax Biotech (4726) has a Capital Reinvestment Ratio of 5.90x as of March 2025, meaning it reinvests 6% of its operating cash flow (NT$14.29 Million) in capital expenditures (NT$84.30 Million). Check tangible net worth ratio of Mycenax Biotech to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Mycenax Biotech Capital Reinvestment Ratio (2020–2020)
This chart tracks Mycenax Biotech's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Mycenax Biotech cash conversion from operations.
Annual Capital Reinvestment Ratio for Mycenax Biotech (2020–2020)
Year-by-year Capital Reinvestment Ratio for Mycenax Biotech from 2020 to 2020. See cash generation quality of Mycenax Biotech to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 1.49x | NT$174.17 Million | NT$260.22 Million | — |